Vectus Biosystems Limited (ASX: VBS)
Sector: Health Care
Market cap: A$5M (as of 2 Nov 2026)
Medical research and development. Phase I human trials for anti-fibrotic drug VB0004 completed.
Data as of 2 Nov 2026.
Recent capital raises
Substantial holders — latest moves
| Date | Holder | Move | Holding | Source |
|---|---|---|---|---|
| 29 May 2026 | REGAL FUNDS MANAGEMENT PTY LIMITED AND ASSOCIATES | Decrease | 8.430% → 6.520% | Filing ↗ |
| 27 May 2026 | Kefford Holdings Pty Ltd ATF The Kefford Family Trust | Increase | 9.830% → 11.580% | Filing ↗ |
| 29 Sept 2025 | Kefford Holdings Pty Ltd <The Kefford Family A/C> | Entry | ?% → 9.73% | Filing ↗ |
| 30 Sept 2024 | Kefford Holdings Pty Ltd <The Kefford Family A/C> | Entry | — | Filing ↗ |
| 6 Dec 2023 | REGAL FUNDS MANAGEMENT PTY LIMITED AND ASSOCIATES | Decrease | 9.43% → 8.43% | Filing ↗ |
Cash and runway
Ask about VBS in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has VBS raised money in the last year, and at what discount?
- What was VBS's latest cash position and runway?
Loading VBS…